Why protocols use repeat dosing rather than a single shot
Quick answer
Most renal stem cell protocols use repeat dosing because MSCs act by secreting anti-inflammatory factors rather than engrafting permanently, and infused cells are cleared fairly quickly. The actual number of sessions and intervals come from the study protocol and physician assessment, not from advertised figures.
Studies show intravenously infused cells are largely trapped in the lungs first before redistributing, so the effect comes from signals released over a window of time, not from becoming new kidney tissue. That is the biological rationale for repeat dosing.
Interval choice balances sustaining the biological effect against safety and the travel burden on international patients. Too frequent means constant flights; too spread out risks losing continuity of any expected effect.
Ask for the schedule in writing: number of sessions, cell dose per session, dates and what happens if a session is postponed. Undocumented mid-course changes are where billing disputes start.
No evidence supports more-is-better; the right dose is the one the protocol sets from safety data.
Tell the team immediately to reschedule; do not substitute an infusion elsewhere on your own.
Keep blood pressure and glucose controlled, follow fluid advice and strictly avoid nephrotoxic drugs.
Allergic reactions and fluid load must be monitored each time, so post-infusion observation matters as much as the infusion.
There is no scientific consensus; decide from measured follow-up results, not from a marketing package.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories